There’s an Opportunity for Big Pharma to Redeem Itself

Joe Nocera writes in Bloomberg Businessweek this week that pharmaceutical companies could use a win by bringing to market a safe and effective Covid-19 vaccine. The industry could use some good PR. Nocera writes:

“Major pharmaceutical companies are viewed by many consumers as greedy and heartless, caring more about their stock price than the people who need their drugs. They take old drugs like insulin, which cost $21 per vial two decades ago, and run the price up to $321. They bring new drugs to market with price tags that can exceed…